Gastrointestinal bleeding: Secondary prophylaxis for variceal bleeding

Nature Reviews Gastroenterology and Hepatology

Volumn 7, Issue 1, 2010, Pages 10-11

  Kravetz, David ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LIVER CIRRHOSIS; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; SECONDARY PREVENTION; SHORT SURVEY; STOMACH VARICES BLEEDING;

ADRENERGIC BETA-ANTAGONISTS; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; GASTROPLASTY; HUMANS; ISOSORBIDE DINITRATE; NITRIC OXIDE DONORS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; SCLEROTHERAPY; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 74949123082     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2009.216     Document Type: Short Survey

References (12)

1. Pagliaro, L. et al. in Portal Hypertension: Pathophysiology and Treatment (eds Bosch, J. & Groszmann, R.J.) 72-92 (Blackwell, Oxford, 1994).
2. Lebrec, D. & stiegmann, G. in Portal Hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology & Therapeutic Strategy (ed. de Franchis, R.) 170-179 (Blackwell, Oxford, 2001).
3. D'Amico, G., Pagliaro, L. & Bosch, J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin. Liver Dis. 19, 475-505 (1999). (Pubitemid 30032646)
4. Gournay, J., Masliha, C., Martin, T., Perrin, D. & Galmiche, J. P. isosorbide mononitrate and propanolol compared with propranolol alone for the prevention of variceal rebleeding. Hepatology 31, 1239-1245 (2000).
5. de Franchis, R. Updating consensus in portal hypertension: report of the Baveno iii consensus workshop on definitions, methodology and Therapeutic strategies in portal hypertension. J. Hepatol. 33, 846-852 (2000).
6. Laine, L., El newihi, H. M., Migikovsky, B., sloane, R. & Garcia, F. endoscopic ligation compared with scleroTherapy for the treatment of bleeding esophageal varices. Ann. Intern. Med. 119, 1-7 (1993).
7. Lo, G. et al. endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 32, 461-465 (2000).
8. de la Peña, J. et al. variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 41, 572-578 (2005).
9. Gonzales, R. et al. Meta-analysis: combination endoscopic and drug Therapy to prevent variceal rebleeding in cirrhosis. Ann. Intern. Med. 149, 109-122 (2008).
10. Garcia-Pagan, J. C. et al. nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of variceal rebleeding: a multicentre randomized controlled trial. Gut 58, 1144-1150 (2009).
11. Kumar, A. et al. Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence. Gastroenterology 137, 892-901 (2009).
12. Burroughs, A. K. et al. in Portal Hypertension IV. Proceedings of the Fourth Baveno International Consensus Workshop on Definitions, Methodology & Therapeutic Strategy (ed. de Franchis, R.) 11-39 (wiley-Blackwell, Oxford, 2006).